Skip to news
JQJO
Latest

Novo Nordisk Cuts Wegovy Price to Combat Competition | JQJO

Novo Nordisk Cuts Wegovy Price to Combat Competition

Novo Nordisk Cuts Wegovy Price to Combat Competition

Tap title to read story

0:00 / 0:00

Novo Nordisk announced a price reduction for its weight-loss drug Wegovy to $499 per month for uninsured patients, delivered to their homes. This follows Eli Lilly's recent price cut for its competitor, Zepbound. The move aims to undercut compounding pharmacies that have been selling cheaper copies of Wegovy, which the FDA recently removed from its shortage list. Novo Nordisk's stock price rose following the announcement, while that of a telehealth company selling compounded Wegovy fell.

Published · Published by JQJO

Published by JQJO Editorial Desk · AI assisted

JQJO Editorial Desk · Human reviewed · AI assisted. Report a correction.

Editorial policy and corrections · Our team

Glenn Close, Ridley Scott Honored

Tap title to read story

0:00 / 0:41

Apple Launches Health‑AI Study App

Tap title to read story

0:00 / 0:38

California Coast Hit by Massive Waves

Tap title to read story

0:00 / 0:35

JQJO

Find your next story

Search JQJO’s current coverage.